LEIDOS BIOMEDICAL RESEARCH INC - ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

On Jan 29, 2026, Department of Health and Human Services obligated $141,656,003 to LEIDOS BIOMEDICAL RESEARCH INC for advance universal influenza vaccine - flu mosaic version 2 (flumosv2). The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Jan 28, 2031. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.